AKTIS ONCOLOGY, INC. COMMON STOCK reports a Return on Equity (ROE) of -11.95%.

What is AKTS's dividend yield?

AKTIS ONCOLOGY, INC. COMMON STOCK offers a dividend yield of 0.00%.

What is AKTS's Deepscope Quality Score?

Deepscope rates AKTS's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy AKTS?

Deepscope's AI Timing Score for AKTS is 69 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does AKTS belong to?

AKTIS ONCOLOGY, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

AKTS (NASDAQ) Stock Analysis | AKTIS ONCOLOGY, INC. COMMON STOCK

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

AKTS

AKTIS ONCOLOGY, INC. COMMON STOCK

US:NASDAQ STOCK Healthcare >> Biotechnology News 75

USD 18.87

-1.02 (-5.13%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-12.0%

ROE

-10.5%

ROA

0.00%

Div Yield

AKTIS ONCOLOGY, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 18.87 Price -1.02 (-5.13%) Day Change	NEWS SCORE: 75

AKTS, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	75
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	18.87
PBV / Sector	2.12 / 4.63
Earning Per Share	-1.07

PE / Sector	N/A / 17.43
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	2.91 M GREAT
Average 1W Daily Value	3.79 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-809.20 / 449.48
NPM Average (%) / Sector	-1,213.34 / -1,506.49
NPM Change Average (%) / Sector	N/A / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-10.49 / 30.58
ROA Average (%) / Sector	-16.88 / -347.17
ROA Change Average (%) / Sector	15.06 / 5,125.52 GOOD
ROE (%) / Sector	-11.95 / -3.58
ROE Average (%) / Sector	47.37 / 40.65 GREAT
ROE Change Average (%) / Sector	-48.26 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Registration Details

Analyze Date	2026-06-06 09:08:26
Symbol	AKTS
Name	AKTIS ONCOLOGY, INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	53.40 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,070.72 / 8,857.28

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 17 Drydock Avenue, Boston, MA, United States, 02210

Phone: 617 461 4023

Website: https://www.aktisoncology.com

Employees: 79

Sector: Healthcare >> Biotechnology

Description: Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts.